Lactobacillus paracasei strain
US-12152232-B2 · Nov 26, 2024 · US
US9895401B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9895401-B2 |
| Application number | US-201615097847-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 13, 2016 |
| Priority date | Jun 10, 2011 |
| Publication date | Feb 20, 2018 |
| Grant date | Feb 20, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed are novel Lactobacillus plantarum strains as well as a composition containing the novel Lactobacillus plantarum strains or a culture thereof.
Opening claim text (preview).
The invention claimed is: 1. A method of treating diarrhea, said method comprising administering an effective dose of Lactobacillus plantarum APsulloc 331263 (Accession No. KCCM11180P) strain, an extract thereof, or a culture solution thereof to a subject in need of treating diarrhea, wherein the strain has acid resistance at pH 2 to pH 4, and wherein the strain has bile resistance at 0.3-0.5% bile concentration, wherein the strain does not ferment rhamnose, inulin, or xylitol, wherein the strain produces D-type lactic acid in an amount of 70% or less based on a sum of amounts of the D-type lactic acid and L-type lactic acid produced. 2. The method according to claim 1 , wherein the strain, the extract thereof, or the culture solution thereof is administered in a composition, wherein the composition further comprises at least one of a surfactant, excipient, wetting agent, emulsifier, suspending agent, salt or buffer for osmotic pressure control, colorant, flavoring agent, stabilizer, preservative, and preserved agent. 3. The method according to claim 1 , wherein the strain is isolated from tea tree ( Camellia sinensis ) leaves. 4. The method according to claim 1 , wherein the strain has acid resistance at pH 2 to pH 4 for 0.5 hour to 5 hours. 5. The method of claim 1 , wherein the effective dose is 0.1 mg/kg/day to 5000 mg/kg/day. 6. The method of claim 1 , wherein administration is oral or parenteral.
Lactobacilli, e.g. L. acidophilus or L. brevis · CPC title
Laxatives · CPC title
Theaceae (Tea family), e.g. camellia · CPC title
for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants · CPC title
Microorganisms (addition of bacteria for nutritional purposes A23L33/135) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.